Crossmark

Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis

Crossref DOI link: https://doi.org/10.1016/j.nefro.2025.01.001

Published Print: 2025-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Esteban-Fernández, Alberto https://orcid.org/0000-0002-3839-7336
de Blas-Ruiz, Carlos https://orcid.org/0009-0003-8823-6092
Fernández-Ustoa, Maitane https://orcid.org/0009-0001-1391-8780
Gabaldón-Perucha, Elena

López-Gómez, Beatriz

Ruiz-Martín, Guadalupe
License Information

Text and Data Mining valid from 2025-06-01

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-01-02
More Information

This article is maintained by: Elsevier

Article Title: Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2025.01.001

Content Type: simple-article

Copyright: © 2025 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.